Clinical Trials Browser

Phase 1 × Breast Neoplasms × Tamoxifen × Clear all

NCT02057133 2026-01-26

A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread

Phase 1 Active not recruiting

Breast Neoplasms

NCT03554044 2025-05-21

T-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast Cancer

Phase 1 Completed

Breast Neoplasms

NCT00424164 2024-03-08

LAPATAM

Phase 1 Completed

Breast Neoplasms, Breast Neoplasms, Male

NCT04961632 2024-02-01

Dose-determining and Dose-confirmatory Study to Investigate the Optimal Dose of Tamoxifen in Breast Cancer Patients According to Genotype Status of TCF20 rs932376

Phase 1 Unknown

Breast Neoplasms

NCT02586675 2022-01-21

TEEL Study- Phase 1 Tamoxifen and Ribociclib (LEE011) in Advanced ER+ (HER2 Negative) Breast Cancer

Phase 1 Completed

7 enrolled 8 charts

Breast Neoplasms, Neoplasm Metastasis, Breast Neoplasms, Male

NCT02936206 2021-05-19

Examination of Breast Cancer Cells of Pre-menopausal and Post-menopausal Women Before and After Exposure to Tamoxifen or Fulvestrant.

Phase 1 Terminated

2 enrolled 5 charts

Breast Neoplasms

NCT01192308 2020-12-01

KINETAM

Phase 1 Completed

Breast Neoplasms

NCT00005886 2017-01-13

Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast Cancer

Phase 1 Completed

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00009997 2011-03-28

Trastuzumab and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer

Phase 1 Completed

Breast Neoplasms

NCT00005822 2010-06-11

SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer

Phase 1 Completed

Breast Neoplasms, Breast Neoplasms, Male, Inflammatory Breast Neoplasms